🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the UK / NCT07295379
Active, not recruiting Observational

LIQUIBAND FIX8® for Ventral Incisional Hernia

NCT07295379 · tracked via the Priya Life Science UK tracker
Sponsor
Advanced Medical Solutions Ltd.
Phase
Observational
Started
2026-02-02
Last updated
2026-07-08

Condition(s) studied

Hernia Incisional Ventral

Investigational drug(s) / intervention(s)

LIQUIBAND FIX8

LIQUIBAND FIX8: Study device

Study summary

This study is designed to evaluate the safety and performance of device LiquiBand FIX8 Open hernia mesh fixation device. The use of this device is not experimental, as it is already approved for use in the EU (CE-marked). This is a retrospective post market clinical follow-up study to collect information about the use of the device in a real-world setting for ventral incisional hernia repair. Ventral incisional hernias occur following surgery and the most common method of treatment includes implanting a mesh, which in the case of ventral incisional hernia, the standard of care is intra-peritoneal onlay mesh. This is fixed in place using sutures, tacks or adhesive.

The LiquiBand FIX8 Open device is an atraumatic device specifically engineered for strong mesh fixation of hernia repair meshes. Hernia repair meshes are woven sheets of flexible synthetic plastic which are placed tension-free over the weakness in the peritoneum abdominal wall, essentially 'plugging' it up. Tension is created in the abdominal wall during repair, but the mesh allows this tension to be spread out. The mesh must be secured to the underlying tissue and this is often done with the use of tacks or sutures, however, the study device instead uses a glue (N-Butyl 2 cyanoacrylate adhesive) to secure the mesh. The FIX8 Open device is designed for the application of this glue to the implanted hernia repair mesh in order to fix the mesh to the underlying tissue. When the glue is applied to the mesh and tissue, it polymerises (forms a chemical bond) due to the moisture on the tissue surface within approximately 10 seconds and allows the mesh to remain in the correct position. The study device can also be used to close topical wounds (the opening that the surgeon makes on the surface to access the hernia).

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * Patient is ≥ 18 years of age and ≤ 80 years of age. * Patient had a ventral incisional hernia (this may include both primary and recurrent). * Patient underwent a ventral incisional repair and LIQUIBAND FIX8® adhesive was used for mesh fixation (including those patients where supplemental fixation was used) * Has a minimum of 12 months follow-up. Exclusion Criteria: * Concomitant parastomal hernia repair * No other exclusions specific to the device

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Royal Lancaster Infirmary Lancaster United Kingdom

More Advanced Medical Solutions Ltd. trials in the UK

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07295379 on ClinicalTrials.gov ↗ ← All trials in the UK